132 related articles for article (PubMed ID: 28161643)
1. SIRT3 deacetylated and increased citrate synthase activity in PD model.
Cui XX; Li X; Dong SY; Guo YJ; Liu T; Wu YC
Biochem Biophys Res Commun; 2017 Mar; 484(4):767-773. PubMed ID: 28161643
[TBL] [Abstract][Full Text] [Related]
2. Regulation of SIRT3 on mitochondrial functions and oxidative stress in Parkinson's disease.
Shen Y; Wu Q; Shi J; Zhou S
Biomed Pharmacother; 2020 Dec; 132():110928. PubMed ID: 33128944
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Sirt3 inhibits lipid accumulation in macrophages through mitochondrial IDH2 deacetylation.
Sheng S; Kang Y; Guo Y; Pu Q; Cai M; Tu Z
Int J Clin Exp Pathol; 2015; 8(8):9196-201. PubMed ID: 26464666
[TBL] [Abstract][Full Text] [Related]
4. Obesity and aging diminish sirtuin 1 (SIRT1)-mediated deacetylation of SIRT3, leading to hyperacetylation and decreased activity and stability of SIRT3.
Kwon S; Seok S; Yau P; Li X; Kemper B; Kemper JK
J Biol Chem; 2017 Oct; 292(42):17312-17323. PubMed ID: 28808064
[TBL] [Abstract][Full Text] [Related]
5. SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status.
Yu W; Dittenhafer-Reed KE; Denu JM
J Biol Chem; 2012 Apr; 287(17):14078-86. PubMed ID: 22416140
[TBL] [Abstract][Full Text] [Related]
6. SIRT3 and GCN5L regulation of NADP+- and NADPH-driven reactions of mitochondrial isocitrate dehydrogenase IDH2.
Smolková K; Špačková J; Gotvaldová K; Dvořák A; Křenková A; Hubálek M; Holendová B; Vítek L; Ježek P
Sci Rep; 2020 May; 10(1):8677. PubMed ID: 32457458
[TBL] [Abstract][Full Text] [Related]
7. PGC-1α/ERRα-Sirt3 Pathway Regulates DAergic Neuronal Death by Directly Deacetylating SOD2 and ATP Synthase β.
Zhang X; Ren X; Zhang Q; Li Z; Ma S; Bao J; Li Z; Bai X; Zheng L; Zhang Z; Shang S; Zhang C; Wang C; Cao L; Wang Q; Ji J
Antioxid Redox Signal; 2016 Feb; 24(6):312-28. PubMed ID: 26421366
[TBL] [Abstract][Full Text] [Related]
8. Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress.
Shi H; Deng HX; Gius D; Schumacker PT; Surmeier DJ; Ma YC
Hum Mol Genet; 2017 May; 26(10):1915-1926. PubMed ID: 28369333
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Sirtuin Network Reveals Dynamic SIRT3-Dependent Deacetylation in Response to Membrane Depolarization.
Yang W; Nagasawa K; Münch C; Xu Y; Satterstrom K; Jeong S; Hayes SD; Jedrychowski MP; Vyas FS; Zaganjor E; Guarani V; Ringel AE; Gygi SP; Harper JW; Haigis MC
Cell; 2016 Nov; 167(4):985-1000.e21. PubMed ID: 27881304
[TBL] [Abstract][Full Text] [Related]
10. Regulation of mitochondrial F(o)F(1)ATPase activity by Sirt3-catalyzed deacetylation and its deficiency in human cells harboring 4977bp deletion of mitochondrial DNA.
Wu YT; Lee HC; Liao CC; Wei YH
Biochim Biophys Acta; 2013 Jan; 1832(1):216-27. PubMed ID: 23046812
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial SIRT3 and its target glutamate dehydrogenase are altered in follicular cells of women with reduced ovarian reserve or advanced maternal age.
Pacella-Ince L; Zander-Fox DL; Lan M
Hum Reprod; 2014 Jul; 29(7):1490-9. PubMed ID: 24771001
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol regulates mitochondrial reactive oxygen species homeostasis through Sirt3 signaling pathway in human vascular endothelial cells.
Zhou X; Chen M; Zeng X; Yang J; Deng H; Yi L; Mi MT
Cell Death Dis; 2014 Dec; 5(12):e1576. PubMed ID: 25522270
[TBL] [Abstract][Full Text] [Related]
13. Hypertrophic preconditioning attenuates myocardial ischemia/reperfusion injury through the deacetylation of isocitrate dehydrogenase 2.
Ma L; Shi H; Li Y; Gao W; Guo J; Zhu J; Dong Z; Sun A; Zou Y; Ge J
Sci Bull (Beijing); 2021 Oct; 66(20):2099-2114. PubMed ID: 36654268
[TBL] [Abstract][Full Text] [Related]
14. Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies.
Yu W; Denu RA; Krautkramer KA; Grindle KM; Yang DT; Asimakopoulos F; Hematti P; Denu JM
J Biol Chem; 2016 Feb; 291(7):3268-79. PubMed ID: 26631723
[TBL] [Abstract][Full Text] [Related]
15. Exogenous H
Sun Y; Tian Z; Liu N; Zhang L; Gao Z; Sun X; Yu M; Wu J; Yang F; Zhao Y; Ren H; Chen H; Zhao D; Wang Y; Dong S; Xu C; Lu F; Zhang W
J Mol Med (Berl); 2018 Apr; 96(3-4):281-299. PubMed ID: 29349500
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule inhibitors at the PSD-95/nNOS interface attenuate MPP+-induced neuronal injury through Sirt3 mediated inhibition of mitochondrial dysfunction.
Hu W; Guan LS; Dang XB; Ren PY; Zhang YL
Neurochem Int; 2014 Dec; 79():57-64. PubMed ID: 25452082
[TBL] [Abstract][Full Text] [Related]
17. miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3.
Geng L; Zhang T; Liu W; Chen Y
Neurosci Lett; 2018 May; 675():23-30. PubMed ID: 29567426
[TBL] [Abstract][Full Text] [Related]
18. Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria.
Cimen H; Han MJ; Yang Y; Tong Q; Koc H; Koc EC
Biochemistry; 2010 Jan; 49(2):304-11. PubMed ID: 20000467
[TBL] [Abstract][Full Text] [Related]
19. SIRT1 overexpression in skeletal muscle in vivo induces increased insulin sensitivity and enhanced complex I but not complex II-V functions in individual subsarcolemmal and intermyofibrillar mitochondria.
Zhang HH; Qin GJ; Li XL; Zhang YH; Du PJ; Zhang PY; Zhao YY; Wu J
J Physiol Biochem; 2015 Jun; 71(2):177-90. PubMed ID: 25782776
[TBL] [Abstract][Full Text] [Related]
20. SIRT3, a mitochondrial NAD⁺-dependent deacetylase, is involved in the regulation of myoblast differentiation.
Abdel Khalek W; Cortade F; Ollendorff V; Lapasset L; Tintignac L; Chabi B; Wrutniak-Cabello C
PLoS One; 2014; 9(12):e114388. PubMed ID: 25489948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
